Cargando…
A Novel mRNA Signature Related to Immunity to Predict Survival and Immunotherapy Response in Hepatocellular Carcinoma
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is the most common primary liver cancer and the incidence and mortality rates are increasing. Given the limited treatments of HCC and promising application of immunotherapy for cancer, we aimed to identify an immune-related prognostic signature tha...
Autores principales: | Zhou, Chenhao, Weng, Jialei, Gao, Yuan, Liu, Chunxiao, Zhu, Xiaoqiang, Zhou, Qiang, Li, Chia-Wei, Sun, Jialei, Atyah, Manar, Yi, Yong, Ye, Qinghai, Shi, Yi, Dong, Qiongzhu, Liu, Yingbin, Hung, Mien-Chie, Ren, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547263/ https://www.ncbi.nlm.nih.gov/pubmed/36304510 http://dx.doi.org/10.14218/JCTH.2021.00283 |
Ejemplares similares
-
Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma
por: Weng, Jialei, et al.
Publicado: (2021) -
GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism()
por: Zhou, Qiang, et al.
Publicado: (2022) -
Low expression of WW domain‐containing oxidoreductase associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Zhou, Chenhao, et al.
Publicado: (2018) -
The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients
por: Atyah, Manar, et al.
Publicado: (2022) -
Development and validation of a nomogram combining hematological and imaging features for preoperative prediction of microvascular invasion in hepatocellular carcinoma patients
por: Zhou, Qiang, et al.
Publicado: (2021)